Bispecific binding agents for modulating biological activity

Details for Australian Patent Application No. 2005249396 (hide)

Owner Merrimack Pharmaceuticals, Inc.

Inventors Nielsen, Ulrik, B.; Schoeberl, Birgit, M.

Agent Pizzeys

Pub. Number AU-B-2005249396

PCT Pub. Number WO2005/117973

Priority 60/568,656 05.05.04 US

Filing date 5 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 20 October 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/117973 Priority application(s): WO2005/117973

20 October 2011 Application Accepted

  Published as AU-B-2005249396

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249401-Compositions and methods for treatment of premenstrual dysphoric disorder

2005249393-Preventing autoimmune disease by using an anti-CD20 antibody